Noetik, an AI-native biotech company leveraging self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, announced today that it closed an...
Flagship Pioneering demonstrated further acceleration in its strategic partnership with Pfizer Inc, announcing two research programs with Flagship-founded Quotient Therapeutics. Under the collaboration, the...
Oncoinvent ASA, a clinical stage radiopharmaceutical company advancing alpha emitter therapy across a variety of peritoneal metastases, announced the appointment of Oystein Soug as...
Pillar Biosciences, the leader in Decision Medicine, has announced the global launch of oncoReveal Nexus, a research-use-only (RUO) next-generation sequencing (NGS) kit designed to...
Tonix Pharmaceuticals Holding Corp, a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, and Bilthoven Biologicals (BBio), part of the...
